Join the JICC for a special lecture on photoimmunotherapy, a new type of molecular targeted cancer therapy developed by Professor Hisataka Kobayashi and his colleagues at the National Cancer Institute (NCI)!
Using fluorescent dye with cancer-specific antibodies, scientists at NCI have discovered how to use near-infrared light to burn holes in cancer cells without harming surrounding tissue. On May 11, Professor Hisataka Kobayashi will present this new development in the fight against cancer, examining the science behind the technique, its applications, and the future of cancer treatment.
Registration is required for this event.
Hisataka Kobayashi, M.D., Ph.D.
ABOUT THE PRESENTER
Dr. Hisataka Kobayashi is a tenured senior investigator in the Molecular Imaging Program at the National Cancer Institute/ NIH in Bethesda, MD. Dr. Kobayashi was awarded an M.D. and Ph.D. (Immunology/Medicine) from Kyoto University, Kyoto, Japan. His interest is in developing novel molecular imaging and therapeutic agents or technologies especially for targeting cancers. He has published over 250 scientific articles in clinical and preclinical bio-medical imaging over the last 20 years.
Thursday, May 11th, 2017
from 2:00 PM to 3:00 PM (EDT)
Japan Information & Culture Center, Embassy of Japan
1150 18th Street Northwest
Washington DC 20036 US